Arvind Kejriwal faces ‘nepotism’ in appointment charge

New Delhi: Delhi’s Chief Minister Arvind Kejriwal is facing ‘nepotism’ in appointment charge over allegations that his relative’s appointment was done without any advertisement.

 Delhi's Chief Minister Arvind Kejriwal is facing 'nepotism' in appointment charge.
Delhi’s Chief Minister Arvind Kejriwal is facing ‘nepotism’ in appointment charge.

Delhi Lieutenant Governor Najeeb Jung is probing the appointment of Dr Nikunj Aggarwal as officer on special duty to Delhi Health Minister Satyendra Jain.

Dr Aggarwal is the son-in-law of the sister-in-law of Kejriwal and thus the appointment has elevated curiosity.

He was first appointed as a senior resident doctor for orthopedics. What makes his appointment, at the Chacha Nehru Bal Chikitsalaya, suspicious is that it came at a time when no such post was vacant in the institute.

“Posts are filled through advertising, but in the instant case, the appointment was done without any advertisement,” notes the draft probe report of the three-member Shunglu committee.

A vacant position of faculty in the orthopedics department was adjusted to make way for the entry of Kejriwal’s relative, it states.

Also, the appointment of Dr Aggarwal was done on the basis of a simple hand-written application, without government norms being followed, according to the report.

Within three months, Dr Nikunj Aggarwal was then appointed as the OSD to health minister Jain.

What has raised the hackles of the probe team was a state-sponsored programme for Dr Aggarwal at a top institute.

According to official documents, he was sent, on government expense of Rs 1.15 lakh, to a management-development programme for senior healthcare officials at IIM Ahmedabad.

“Being a senior resident (ad hoc), Dr Aggarwal was not entitled to participate in such types of training at government expense as per residency scheme of the hospital,” says the probe report.

It has also found discrepancies in an order dated July 2016 of the department of health and family welfare, which approved government expenses for his trip to Beijing to attend the China Sinopharm International Corporation.

Inputs with Mail Today
%d bloggers like this: